By Amina Niasse
NEW YORK, April 9 (Reuters) - Amazon.com (AMZN.O) said on Thursday its pharmacy unit will stock Eli Lilly’s (LLY.N) new weight-loss pill at kiosks located at some of the company’s primary care clinics and offer same-day delivery of the drug.
Amazon Pharmacy began delivering GLP-1 medications in 2021, but does not stock injectable versions of the drugs in kiosks because they need to be refrigerated.
No need for cold storage is “what allows for broader access and for them to be stored safely in a kiosk for dispensing,” Tanvi Patel, a vice president at Amazon Pharmacy, said of the pills.
About half of customers in the U.S. have access to same-day delivery, and the company aims to expand that, Patel said. All customers receive their medications within four days.
Amazon Pharmacy fulfills prescriptions made through Eli Lilly’s direct-to-consumer pharmacy platform LillyDirect and has been stocking Novo Nordisk’s (NOVOb.CO) Wegovy pill at its kiosks since January.
Patel said Amazon benefits from being Lilly’s dispensing pharmacy because of the Indianapolis-based drugmaker’s early direct-to-consumer focus.
Lilly said last week it would begin selling its newly approved Foundayo weight-loss pill directly to cash-pay customers through LillyDirect at $149 per month for the lowest dose.
Customers can also access Amazon’s same-day delivery through Lilly’s prescribing partners, such as WeightWatchers (WW.O) , said Patel.
Novo’s rival Wegovy pill, which began selling in January, is currently stocked in five kiosks in California, where customers can pick up the drugs at Amazon’s One Medical locations following a medical appointment.
Amazon last year announced the kiosks for selling widely used medications such as antibiotics, blood pressure medicines and asthma inhalers, saying the option would reduce barriers to access and limit shipping costs.
Patients without a membership to One Medical, Amazon’s primary and urgent care business, can still book an appointment and use the kiosks. A one-year One Medical subscription fee costs $199.
As the kiosks are introduced beyond California, Patel said, their locations may expand to other providers or clinics, if allowed by state regulation.
Amazon invested over $4 billion in 2025 in an effort to triple its company-wide delivery options this year, targeting underserved small towns and rural areas. By the end of 2026, same-day delivery access should reach 4,500 locales, Patel said.

ARKG

- Amazon Pharmacy will stock Eli Lilly’s new weight-loss pill at kiosks in selected primary care clinics, offering same-day delivery for the drug.  
- Since 2021, Amazon Pharmacy has delivered GLP-1 medications but avoids stocking injectable versions due to refrigeration needs, facilitating broader access to the pills.  
- The company aims to expand same-day delivery to 4,500 locations by the end of 2026, having invested over $4 billion in 2025 to enhance delivery options, particularly in underserved areas.

Reuters

SPDR S&P Retail ETF

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bull 3X

Amazon

Health Care Select Sector SPDR

VG Health

Direxion Daily AMZN Bull 2X Shares

ProShares Online Retail

VanEck Biotech ETF

VanEck Retail ETF

iShares US Pharma

Invesco Biotechnology & Genome ETF

Roundhill AMZN WeeklyPay ETF

iShares Biotechnology ETF

Global X E-commerce ETF

ALPS Medical Breakthrough

SPDR S&P Biotech

GraniteShares 2x Long AMZN Daily ETF

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

iShares Global Healthcare

Direxion Daily LLY Bull 2X Shares

Eli Lilly

Amplify Online Retail ETF

Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery